scholarly article | Q13442814 |
P356 | DOI | 10.1016/0092-8674(93)90275-U |
P698 | PubMed publication ID | 8098995 |
P50 | author | Stanley B. Prusiner | Q155380 |
Stephen J DeArmond | Q63437608 | ||
P2093 | author name string | Scott M | |
Groth D | |||
Torchia M | |||
Foster D | |||
Yang SL | |||
P2860 | cites work | Measurement of the scrapie agent using an incubation time interval assay | Q34270376 |
Molecular biology of prion diseases | Q34534878 | ||
Chimeric prion protein expression in cultured cells and transgenic mice | Q36277480 | ||
Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins | Q36721451 | ||
Evidence that the Transmission of One Source of Scrapie Agent to Hamsters Involves Separation of Agent Strains from a Mixture | Q39601572 | ||
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein | Q43522858 | ||
Predicted secondary structure and membrane topology of the scrapie prion protein | Q44073197 | ||
Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis | Q44519112 | ||
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. | Q45962479 | ||
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters | Q45968309 | ||
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. | Q45979200 | ||
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. | Q46025414 | ||
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins | Q46079042 | ||
Scrapie prions aggregate to form amyloid-like birefringent rods | Q46201693 | ||
Further purification and characterization of scrapie prions | Q46764657 | ||
Biological evidence that scrapie agent has an independent genome | Q48251939 | ||
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy | Q48674139 | ||
Encephalopathy in mice produced by inoculation with scrapie brain material. | Q51301574 | ||
Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. | Q52754778 | ||
The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice | Q69226275 | ||
Linkage of prion protein and scrapie incubation time genes | Q70143866 | ||
Monoclonal antibodies to the cellular and scrapie prion proteins | Q70299710 | ||
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters | Q70345462 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prion protein family | Q24724413 |
P304 | page(s) | 979-988 | |
P577 | publication date | 1993-06-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. | |
P478 | volume | 73 |
Q38290309 | A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells |
Q45939477 | A change in the conformation of prions accompanies the emergence of a new prion strain. |
Q43109950 | A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. |
Q33968102 | A molecular switch controls interspecies prion disease transmission in mice |
Q35122347 | A murine model of a familial prion disease. |
Q33967861 | A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice |
Q35852143 | A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. |
Q34454961 | A transmembrane form of the prion protein in neurodegenerative disease |
Q48550880 | A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells |
Q36663046 | Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies |
Q48775242 | Abnormalities in stress proteins in prion diseases |
Q33366539 | Accelerated high fidelity prion amplification within and across prion species barriers. |
Q33813167 | Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations |
Q48168864 | Amino acid sequence of the Felis catus prion protein |
Q37184755 | Amyloidogenesis of natively unfolded proteins |
Q38439914 | Animal models for prion-like diseases. |
Q46161882 | Antibodies inhibit prion propagation and clear cell cultures of prion infectivity |
Q39365772 | Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers |
Q24635252 | Asymptomatic deer excrete infectious prions in faeces |
Q27666974 | Atomic Structures Suggest Determinants of Transmission Barriers in Mammalian Prion Disease |
Q37252008 | Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice |
Q51284198 | Biology and Genetics of PrP Prion Strains. |
Q24529092 | Branched polyamines cure prion-infected neuroblastoma cells |
Q60068724 | Catching the culprit prion |
Q40061707 | Cell Biology Approaches to Studying Prion Diseases |
Q33558398 | Cellular biology of prion diseases |
Q33937043 | Cerebral amyloidosis in prion diseases |
Q28359731 | Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers |
Q33405664 | Characteristics of 263K scrapie agent in multiple hamster species |
Q35194921 | Characterization of Syrian hamster adapted prions derived from L-type and C-type bovine spongiform encephalopathies |
Q42649627 | Characterization of a prion protein (PrP) gene from rabbit; a species with apparent resistance to infection by prions |
Q37006731 | Chimeric elk/mouse prion proteins in transgenic mice |
Q36235271 | Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform |
Q47158648 | Chronic wasting disease (CWD) in cervids |
Q33248701 | Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. |
Q36782262 | Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans |
Q43106197 | Conformation determines the seeding potencies of native and recombinant Tau aggregates |
Q35376718 | Conformational transformation and selection of synthetic prion strains |
Q33449340 | Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo |
Q24564014 | Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins |
Q36892999 | Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? |
Q37627076 | De novo mammalian prion synthesis |
Q41478736 | Deadly conformations--protein misfolding in prion disease |
Q44448848 | Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration |
Q33847297 | Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform |
Q40096957 | Destabilizing polymorphism in cervid prion protein hydrophobic core determines prion conformation and conversion efficiency |
Q48002520 | Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation. |
Q41298105 | Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations |
Q41461364 | Effect of Q211 and K222 PRNP Polymorphic Variants in the Susceptibility of Goats to Oral Infection With Goat Bovine Spongiform Encephalopathy |
Q33840809 | Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. |
Q28540614 | Elements modulating the prion species barrier and its passage consequences |
Q35034201 | Epigenetic dominance of prion conformers |
Q35795039 | Etiology and pathogenesis of prion diseases. |
Q36581272 | Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation |
Q43785458 | Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster |
Q40854367 | Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains |
Q27348644 | Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease |
Q35035428 | Fundamentals of prion biology and diseases |
Q40075626 | Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome |
Q40624569 | Genetics of prion diseases and prion diversity in mice |
Q41689443 | Genetics of prions |
Q28365495 | Glycosylation influences cross-species formation of protease-resistant prion protein |
Q37079425 | H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases |
Q46113920 | Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix |
Q36624152 | Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells |
Q51793976 | Highly promiscuous nature of prion polymerization. |
Q42693681 | Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie |
Q72356037 | Human prion diseases |
Q30639674 | Human prion protein sequence elements impede cross-species chronic wasting disease transmission. |
Q36806018 | Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice |
Q28511061 | Identification of candidate proteins binding to prion protein |
Q33201341 | Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule. |
Q33836445 | Identification of two prion protein regions that modify scrapie incubation time |
Q35641189 | Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein |
Q34358708 | Influence of Mabs on PrP(Sc) formation using in vitro and cell-free systems |
Q35251034 | Inherited prion diseases |
Q40071080 | Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases |
Q34974440 | Insights into the role of the immune system in prion diseases |
Q35750568 | Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers |
Q48963662 | Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice |
Q39250023 | Lysosomal Quality Control in Prion Diseases |
Q30424667 | Mammalian prions: tolerance to sequence changes-how far? |
Q34046721 | Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9. |
Q33281952 | Mapping of possible prion protein self-interaction domains using peptide arrays |
Q37329528 | Measuring prions by bioluminescence imaging |
Q31161627 | Molecular Mechanisms of Chronic Wasting Disease Prion Propagation |
Q41627077 | Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity |
Q83323734 | Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies |
Q42730560 | Molecular basis for transmission barrier and interference between closely related prion proteins in yeast |
Q44833529 | Molecular basis of barriers for interspecies transmissibility of mammalian prions |
Q40624601 | Molecular biology and genetics of prion diseases |
Q46007757 | Molecular properties of complexes formed between the prion protein and synthetic peptides. |
Q34467477 | Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform |
Q36282275 | N-terminally tagged prion protein supports prion propagation in transgenic mice |
Q27625390 | NMR structure of the bovine prion protein |
Q27640537 | NMR structure of the human doppel protein |
Q33582070 | Neurodegeneration in humans caused by prions |
Q48308927 | Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. |
Q41549744 | Of mice and (mad) cows--transgenic mice help to understand prions |
Q46894080 | Pathologic conformations of prion proteins |
Q35122315 | Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment |
Q34628763 | Pharmacological approaches to prion research |
Q26823798 | Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs) |
Q54528615 | Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. |
Q42662000 | Polymorphism of prion protein gene in Arctic fox (Vulpes lagopus). |
Q41607167 | Prion diseases and the BSE crisis |
Q35602374 | Prion diseases: from molecular biology to intervention strategies |
Q36356816 | Prion domains: sequences, structures and interactions |
Q35523444 | Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice |
Q34294957 | Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein |
Q33761104 | Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform |
Q33604091 | Prion protein and species barriers in the transmissible spongiform encephalopathies |
Q34304971 | Prion protein conversion in vitro |
Q54037114 | Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. |
Q34304955 | Prion protein diversity and disease in the transmissible spongiform encephalopathies |
Q33962285 | Prion protein genes and prion diseases: studies in transgenic mice |
Q37373871 | Prion protein misfolding and disease |
Q41618801 | Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice |
Q40537035 | Prion protein transgenes and the neuropathology in prion diseases |
Q39409269 | Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). |
Q37036816 | Prion replication elicits cytopathic changes in differentiated neurosphere cultures |
Q24633319 | Prions |
Q48220367 | Prions and related neurological diseases |
Q40372882 | Prions, beta-sheets and transmissible dementias: is there still something missing? |
Q36548578 | Propagation of prion strains through specific conformers of the prion protein |
Q37221670 | Recombinant human prion protein inhibits prion propagation in vitro |
Q37096971 | Recombinant scrapie-like prion protein of 106 amino acids is soluble |
Q34474868 | Review: contribution of transgenic models to understanding human prion disease. |
Q37922607 | Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases |
Q40139360 | Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins |
Q33930771 | Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody |
Q46879245 | Scrapie prions: a three-dimensional model of an infectious fragment |
Q42957132 | Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice. |
Q30482741 | Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease |
Q42367749 | Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy |
Q33816387 | Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence |
Q34306690 | Spongiform encephalopathies: insights from transgenic models |
Q24641822 | Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice |
Q44208453 | Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response. |
Q34322278 | Structural clues to prion replication |
Q36055574 | Structure of the β2-α2 loop and interspecies prion transmission |
Q54046641 | Synaptic prion protein immuno-reactivity in the rodent cerebellum. |
Q43057853 | Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease |
Q36020398 | Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept |
Q42279018 | The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition |
Q33408170 | The comprehensive native interactome of a fully functional tagged prion protein |
Q33705857 | The genetics of prions--a contradiction in terms? |
Q48629277 | The key must fit: macrophages transport prion infection to the central nervous system and may determine the sites of infection within it. |
Q44437817 | The major species specific epitope in prion proteins of ruminants |
Q35874348 | The prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus |
Q36731455 | The reconstitution of mammalian prion infectivity de novo |
Q36319802 | The risk of transmission of variant Creutzfeldt-Jakob disease via contact lenses and ophthalmic devices |
Q38492754 | The transmissible spongiform encephalopathies of livestock |
Q92460612 | Thermostability as a highly dependent prion strain feature |
Q57825820 | Three-dimensional NMR structure of a self-folding domain of the prion protein PrP(121–231) |
Q34305023 | Three-dimensional structures of prion proteins |
Q35037396 | Transgenesis applied to transmissible spongiform encephalopathies |
Q40954169 | Transgenetics and neuropathology of prion diseases. |
Q40975176 | Transgenetics of prion diseases. |
Q48357484 | Transgenic and knockout mice in research on prion diseases |
Q48715592 | Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection. |
Q58270048 | Transgenic mice in amyloid research: an interpretive review |
Q34304996 | Transgenic studies of the influence of the PrP structure on TSE diseases. |
Q33754930 | Transmission barriers for bovine, ovine, and human prions in transgenic mice |
Q35823555 | Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein |
Q35024303 | Transmission of elk and deer prions to transgenic mice |
Q37596459 | Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. |
Q33580805 | Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein |
Q91588784 | Unique Structural Features of Mule Deer Prion Protein Provide Insights into Chronic Wasting Disease |
Q40168614 | Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. |
Q35420475 | White-tailed deer are susceptible to the agent of sheep scrapie by intracerebral inoculation |
Search more.